PCM
CBST

Palisade Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Palisade Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-222,560
Closed -$22.4M – 523
2014
Q4 		$22.4M Sell
222,560
-81,825
-27% -$6.36M 0.54% 40
2014
Q3 		$20.2M Buy
304,385
+93,512
+44% +$6.14M 0.51% 41
2014
Q2 		$14.7M Buy
210,873
+41,657
+25% +$2.83M 0.36% 99
2014
Q1 		$12.4M Buy
169,216
+7,181
+4% +$535K 0.3% 125
2013
Q4 		$11.2M Buy
162,035
+966
+0.6% +$62.5K 0.29% 136
2013
Q3 		$10.2M Buy
161,069
+116,177
+259% +$7.02M 0.28% 138
2013
Q2 		$2.17M Buy
+44,892
New +$2.21M 0.06% 307

Palisade Capital Management's CBST Position: Q1 2015 in Review

Palisade Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 222,560 shares — an estimated $22.4M sold.

Palisade Capital Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $22.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Palisade Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Palisade Capital Management sold 222,560 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $22.4M.
  • Palisade Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Palisade Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $22.4M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Palisade Capital Management's 13F filing for Q1 2015, filed 13 May 2015.